Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.

× No keyword cloud information.

11 in total

1. Immune agents for the treatment of Devic's neuromyelitis optica.

Authors: R Bergamaschi
Journal: Neurol Sci Date: 2007-10 Impact factor: 3.307

2. Practice current: How do you treat neuromyelitis optica?

Authors: Aravind Ganesh
Journal: Neurol Clin Pract Date: 2017-04

3. [Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group].

Authors: C Trebst; A Berthele; S Jarius; T Kümpfel; S Schippling; B Wildemann; C Wilke
Journal: Nervenarzt Date: 2011-06 Impact factor: 1.214

4. Current and future treatment approaches for neuromyelitis optica.

Authors: Nicolas Collongues; Jérôme de Seze
Journal: Ther Adv Neurol Disord Date: 2011-03 Impact factor: 6.570

5. Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.

Authors: Ilya Ayzenberg; Joanna Schöllhammer; Robert Hoepner; Kerstin Hellwig; Marius Ringelstein; Orhan Aktas; Tania Kümpfel; Markus Krumbholz; Corinna Trebst; Friedemann Paul; Florence Pache; Mark Obermann; Lena Zeltner; Matthias Schwab; Achim Berthele; Sven Jarius; Ingo Kleiter
Journal: J Neurol Date: 2016-01-25 Impact factor: 4.849

Review 6. [Neuromyelitis optica].

Authors: S Jarius; B Wildemann
Journal: Nervenarzt Date: 2007-12 Impact factor: 1.214

7. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system.

Authors: Jiwon Oh; Michael Levy
Journal: Neurol Res Int Date: 2012-01-29

Review 8. Molecular pathogenesis of neuromyelitis optica.

Authors: Wajih Bukhari; Michael H Barnett; Kerri Prain; Simon A Broadley
Journal: Int J Mol Sci Date: 2012-10-11 Impact factor: 5.923

Review 9. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors: Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal: J Neurol Date: 2013-11-23 Impact factor: 4.849

Review 10. Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.

Authors: Giordani Rodrigues Dos Passos; Douglas Kazutoshi Sato; Jefferson Becker; Kazuo Fujihara
Journal: Mediators Inflamm Date: 2016-01-28 Impact factor: 4.711